Apotex Inc. et al. v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2022-00298
Filing Date Dec 9, 2021
Institution Decision Date Feb 9, 2022
Decision Date Nov 9, 2022
Court Patent Trial and Appeal Board
Status Final Written Decision
Appeal2023-1396
Administrative JudgesErica A. Franklin, John G. New, Susan L. C. Mitchell
Judge Writing the Final DecisionErica A. Franklin
Claims Challenged in the Petition: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 26
Claims Instituted: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 26
Claims Invalidated: 1, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 26
Petitioner
Patent Owner
Petitioner Attorneys
5Apotex
Attorney Name: Teresa Stanek Rea
Crowell & Moring
Apotex
Attorney Name: Deborah H. Yellin
Crowell & Moring
Apotex
Attorney Name: Shannon M. Lentz
Crowell & Moring
Apotex
Attorney Name: Thomas A. Albini
Crowell & Moring
Apotex
Attorney Name: Mary Gerritsen
Crowell & Moring
Patent Owner Attorneys
7Regeneron Pharmaceuticals
Attorney Name: Deborah E. Fishman
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Alice Ho
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Victoria Reines
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Jeremy D. Cobb
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: Daniel L. Reisner
Arnold & Porter Kaye Scholer
Regeneron Pharmaceuticals
Attorney Name: David M. Wilkerson
Arnold & Porter Kaye Scholer
Related Patents
Doc No | Title | Issue date |
---|---|---|
09254338 | Use of a VEGF antagonist to treat angiogenic eye disorders | Feb 9, 2016 |